AKT1 and glioblastoma: This gives us confidence in evaluating the top exosomal-miRNA-related pathways for developing promising targeted drugs, such as molecular mechanisms of cancer, glioblastoma multiforme signaling, glioblastoma signaling, PI3K/AKT signaling, and glucocorticoid receptor signaling (Poroyko et al., 2018).